Nasdaq Top Companies List by Market Cap as of January 2024

Nasdaq Top Companies List by Market Cap as of Jan-05-2024, Nasdaq Biggest 500 Companies List by Market Cap, Nasdaq Largest 500 Companies List by market cap as of Jan-05-2024.
Nasdaq Largest and Top 1,000 Companies List in 2024
Nasdaq Largest 1,000 Companies List by Market Cap in 2024, Nasdaq Top 1,000 Companies List by Market Cap in 2024.
Stock Exchange Website
Nasdaq

  1. Surmodics

    World Rank (Jan-05-2024)
    12,792
    Market Cap (Jan-05-2024)
    0.487 Billion USD
    World Rank (Jul-30-2023)
    13,353
    Market Cap (Jul-30-2023)
    0.454 Billion USD
    World Rank (Dec-25-2022)
    12,916
    Market Cap (Dec-25-2022)
    0.463 Billion USD
    World Rank (Jan-07-2022)
    11,823
    Market Cap (Jan-07-2022)
    0.65 Billion USD
    Annual Revenue in USD
    105 Million USD
    Annual Net Income in USD
    4 Million USD
    Annual Results for Period Ending
    Sep-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    SurModics is the leader in surface modification technologies for intravascular medical devices and a provider of chemical components for in vitro diagnostic (IVD) tests and microarrays. The headquarters is in USA.
    Facts About Company
    Surmodics company annual revenue was 99 million USD and annual net loss was -27 as on Sep-2022.
    Company Website
    SURMODICS

  2. RXR Acquisition Corp.

    World Rank (Jan-05-2024)
    13,360
    World Rank (Jul-30-2023)
    13,360
    Market Cap (Jul-30-2023)
    0.432 Billion USD
    World Rank (Dec-25-2022)
    13,360
    Market Cap (Dec-25-2022)
    0.433 Billion USD
    World Rank (Jan-07-2022)
    14,606
    Market Cap (Jan-07-2022)
    0.42 Billion USD
    Headquarters Country
    USA

  3. AnaptysBio Inc.

    World Rank (Jan-05-2024)
    11,751
    Market Cap (Jan-05-2024)
    0.575 Billion USD
    World Rank (Jul-30-2023)
    13,367
    Market Cap (Jul-30-2023)
    0.453 Billion USD
    World Rank (Dec-25-2022)
    9,383
    Market Cap (Dec-25-2022)
    0.831 Billion USD
    World Rank (Jan-07-2022)
    9,972
    Market Cap (Jan-07-2022)
    0.91 Billion USD
    Annual Revenue in USD
    63 Million USD
    Annual Net Income in USD
    -57 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    AnaptysBio is a Clinical Stage Biotechnology company developing first in class immunology therapeutic product candidates to patients. The company annual revenue is 75 million USD and 89 employees as on 2020. The headquarters is in USA.
    Company Website
    ANAPTYSBIO INC

  4. Coherus Biosciences

    World Rank (Jan-05-2024)
    15,058
    Market Cap (Jan-05-2024)
    0.337 Billion USD
    World Rank (Jul-30-2023)
    13,372
    Market Cap (Jul-30-2023)
    0.453 Billion USD
    World Rank (Dec-25-2022)
    12,373
    Market Cap (Dec-25-2022)
    0.502 Billion USD
    World Rank (Jan-07-2022)
    8,781
    Market Cap (Jan-07-2022)
    1.13 Billion USD
    Annual Revenue in USD
    326 Million USD
    Annual Net Income in USD
    -287 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Coherus BioSciences is a Biotechnology company that develops and commercializes high quality therapeutics for major regulated markets. The company annual revenue is 113.6 million USD, net income was 27.9 million USD and 232 employees as on 2020. The headquarters is in USA.
    Company Website
    COHERUS BIOSCIENCES INC

  6. Xperi Corporation

    World Rank (Jan-05-2024)
    13,415
    World Rank (Jul-30-2023)
    13,415
    Market Cap (Jul-30-2023)
    0.451 Billion USD
    World Rank (Dec-25-2022)
    8,003
    World Rank (Jan-07-2022)
    8,003
    Annual Revenue in USD
    892 Million USD
    Annual Net Income in USD
    147 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Company Profile
    Xperi Corporation is a Semiconductor Manufacturing company. The company annual revenue is 390 million USD to 410 million USD and 700 employees as on 2020. The headquarters is in USA.
    Company Website
    XPERI CORPORATION

  7. Castle Biosciences

    World Rank (Jan-05-2024)
    11,942
    Market Cap (Jan-05-2024)
    0.559 Billion USD
    World Rank (Jul-30-2023)
    13,423
    Market Cap (Jul-30-2023)
    0.449 Billion USD
    World Rank (Dec-25-2022)
    11,153
    Market Cap (Dec-25-2022)
    0.612 Billion USD
    World Rank (Jan-07-2022)
    9,476
    Market Cap (Jan-07-2022)
    0.99 Billion USD
    Annual Revenue in USD
    94 Million USD
    Annual Net Income in USD
    -31 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Castle Biosciences is Develops and Commercializes Diagnostic and Prognostic Tests for Dermatologic Cancers company. The company annual revenue is 60.1 million USD and 112 employees as on 2020. The headquarters is in USA.
    Company Website
    CASTLE BIOSCIENCES

  9. Allakos

    World Rank (Jan-05-2024)
    16,990
    Market Cap (Jan-05-2024)
    0.239 Billion USD
    World Rank (Jul-30-2023)
    13,456
    Market Cap (Jul-30-2023)
    0.447 Billion USD
    World Rank (Dec-25-2022)
    10,705
    Market Cap (Dec-25-2022)
    0.659 Billion USD
    World Rank (Jan-07-2022)
    13,924
    Market Cap (Jan-07-2022)
    0.46 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -153 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    ALLAKOS is Biotechnology sector company with headquarters is in USA.They are developing therapeutic antibodies for inhibitory receptors on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases
    Company Website
    ALLAKOS

  10. Intercept Pharmaceuticals

    World Rank (Jan-05-2024)
    13,459
    World Rank (Jul-30-2023)
    13,459
    Market Cap (Jul-30-2023)
    0.447 Billion USD
    World Rank (Dec-25-2022)
    12,555
    Market Cap (Dec-25-2022)
    0.490 Billion USD
    World Rank (Jan-07-2022)
    14,284
    Market Cap (Jan-07-2022)
    0.44 Billion USD
    Annual Revenue in USD
    313 Million USD
    Annual Net Income in USD
    -275 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Company Profile

    Intercept Pharmaceuticals is a biotechnology sector company. The headquarters is in USA.

    Company Website
    INTERCEPT PHARMACEUTICALS INC

Share